Notatum-Quentans (USPharmaCo)


Welcome to the PulseAid listing for the Notatum-Quentans drug offered from USPharmaCo. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: USPharmaCo
NON-PROPRIETARY NAME: Penicillium chrysogenum var. chrysogenum and Penicillium glabrum
SUBSTANCE NAME: PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SUSPENSION/ DROPS
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-12-15
END MARKETING DATE: 0000-00-00


Notatum-Quentans HUMAN OTC DRUG Details:

Item DescriptionNotatum-Quentans from USPharmaCo
LABELER NAME: USPharmaCo
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4([hp_X]/10mL; [hp_X]/10mL)
START MARKETING DATE: 2009-12-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49693-1604_fecf48bb-b6bc-4185-88cf-95f1f6631be6
PRODUCT NDC: 49693-1604
APPLICATION NUMBER:

Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BioResource Inc.Notatum-Quentans Nasal 4X
sanPharma GmbHNotaQuenSAN
Sanum-Kehlbeck GmbH & Co. KGPleo Nota-Quent
Syntrion GmbHSyInfect
USPharmaCoNotatum-Quentans